Nielsen, Peter G.,Thomsen, Mikael S.,Højgaard, Bent
申请号：
AU2016228002
公开号：
AU2016228002A1
申请日:
2016.03.02
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity or an obesity associated disorder.
